Skip to content

Evaluation of the impact of the moisturizing milk RV2478B on the use of corticoids and on quality of life, in a population of children with atopic dermatitis.

Evaluation of the impact of the moisturizing milk RV2478B on the use of corticoids and on quality of life, in a population of children with atopic dermatitis.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2004-002926-23-IT
Enrollment
210
Registered
2007-01-15
Start date
2004-12-22
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic dermatitis MedDRA version: 6.1 Level: PT Classification code 10012438

Interventions

Product Code: RV2478B Pharmaceutical Form: Ointment INN or Proposed INN: Emollients and protectives Current Sponsor code: RV2478B Other descriptive name: Dermocosmetic milk Concentration unit: % perce

Sponsors

INSTITUT DE RECHERCHE PIERRE FABRE
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026